These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7000464)

  • 1. Effects of captopril in animal models of hypertension.
    Antonaccio MJ; Rubin B; Horovitz ZP
    Clin Exp Hypertens (1978); 1980; 2(3-4):613-37. PubMed ID: 7000464
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacological effects of captopril].
    Rubin B; Antonaccio J
    Nouv Presse Med; 1981 Apr; 10(19):1531-46. PubMed ID: 6269555
    [No Abstract]   [Full Text] [Related]  

  • 3. Captopril--indications and clinical problems.
    Schaefer RM; Heidland A
    Contrib Nephrol; 1984; 43():182-203. PubMed ID: 6435949
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of inhibition of converting enzyme by captopril on arterial pressure, renin and aldosterone in essential hypertension].
    Posadas C; Sánchez G; Boyer JL; Delmar M; Serrano PA
    Arch Inst Cardiol Mex; 1982; 52(4):295-300. PubMed ID: 6291470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of the antihypertensive action of captopril.
    Mann JF
    Contrib Nephrol; 1984; 43():171-81. PubMed ID: 6386325
    [No Abstract]   [Full Text] [Related]  

  • 6. Effective use of captopril (angiotensin I-converting enzyme inhibitor) in severe childhood hypertension.
    Friedman A; Chesney RW; Ball D; Goodfriend T
    J Pediatr; 1980 Oct; 97(4):664-7. PubMed ID: 6999143
    [No Abstract]   [Full Text] [Related]  

  • 7. Hormonal changes with long-term converting-enzyme inhibition by captopril in essential hypertension.
    Matthews PG; McGrath BP; Johnston CI
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():135s-138s. PubMed ID: 232017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The kidney as an endocrine organ. II. Vasodepressors].
    de Leeuw PW; Birkenhäger WH
    Ned Tijdschr Geneeskd; 1978 Apr; 122(17):583-96. PubMed ID: 349407
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy of captopril in experimental low renin hypertension.
    Tikkanen I; Fyhrquist F; Tikkanen T; Miettinen A
    Eur J Pharmacol; 1980 Nov; 68(2):197-200. PubMed ID: 7009165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of captopril and hydrochlorothiazide on the response to pressor agents in hypertensives.
    Fruncillo RJ; Rotmensch HH; Vlasses PH; Koplin JR; Swanson BN; Ferguson RK
    Eur J Clin Pharmacol; 1985; 28(1):5-9. PubMed ID: 3886401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A new point of attack for the treatment of hypertension; captopril, an orally active inhibitor of the enzymatic conversion of angiotensin I into angiotensin II].
    Schalekamp MA; de Bruyn JH; Wenting GJ; Man in 't Veld AJ; Derkx FH
    Ned Tijdschr Geneeskd; 1980 Nov; 124(47):1996-2003. PubMed ID: 6255350
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term effects of captopril (SQ14 225) on blood-pressure and hormone levels in essential hypertension.
    Johnston CI; Millar JA; McGrath BP; Matthews PG
    Lancet; 1979 Sep; 2(8141):493-6. PubMed ID: 90216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Captopril in hypertension with renal artery stenosis and in intractable hypertension; acute and chronic changes in circulating concentrations of renin, angiotensins I and II and aldosterone, and in body composition.
    Atkinson AB; Brown JJ; Fraser R; Leckie B; Lever AF; Morton JJ; Robertson JI
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():139s-143s. PubMed ID: 396067
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of captopril on renal hemodynamics in hypertensive patients.
    Duchin KL; Willard DA
    J Clin Pharmacol; 1984; 24(8-9):351-9. PubMed ID: 6384279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of renal prostaglandins in circulatory homeostasis.
    Staszewska-Barczak J
    Contrib Nephrol; 1978; 11():179-88. PubMed ID: 699589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug therapy. Captopril.
    Vidt DG; Bravo EL; Fouad FM
    N Engl J Med; 1982 Jan; 306(4):214-9. PubMed ID: 7033784
    [No Abstract]   [Full Text] [Related]  

  • 17. Angiotensin-converting enzyme inhibitors: pathogenic and therapeutic implications for arterial hypertension.
    Waeber B; Brunner HR; Wauters JP; Gavras H
    Adv Nephrol Necker Hosp; 1981; 10():111-33. PubMed ID: 6267906
    [No Abstract]   [Full Text] [Related]  

  • 18. Angiotensin converting enzyme (ACE) inhibitors.
    Antonaccio MJ
    Annu Rev Pharmacol Toxicol; 1982; 22():57-87. PubMed ID: 6282189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitors of angiotensin-converting enzyme.
    Cushman DW; Ondetti MA; Cheung HS; Antonaccio MJ; Murthy VS; Rubin B
    Adv Exp Med Biol; 1980; 130():199-225. PubMed ID: 6250340
    [No Abstract]   [Full Text] [Related]  

  • 20. Captopril in clinical hypertension. Changes in components of renin-angiotensin system and in body composition in relation to fall in blood pressure with a note on measurement of angiotensin II during converting enzyme inhibition.
    Atkinson AB; Morton JJ; Brown JJ; Davies DL; Fraser R; Kelly P; Leckie B; Lever AF; Robertson JI
    Br Heart J; 1980 Sep; 44(3):290-6. PubMed ID: 7000102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.